A new model for curing disease
Mission: Cure is a nonprofit founded in 2017 to improve the health and lives of people affected by costly diseases with poor outcomes, starting with pancreatitis.
We are an alliance of patients, caregivers, doctors, researchers, drug developers, and entrepreneurs pioneering a new approach to curing diseases using cutting-edge science, innovative financing, and patient-driven solutions recognized around the world.
Our Target is Chronic Pancreatitis
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments.
Mission: Cure is working to make that happen. Consulting with pancreatic experts from the world’s top research and healthcare institutions, we developed a plan and are working to implement it.
Our Approach
Financing Based on Patient Outcomes
Promising and Cost-Effective Methods to Cure Diseases
Active Collaboration Among Stakeholders
Partnerships with Impact Investors
Our Impact
Together, We’re Changing the Future of Pancreatitis​
People empowered by our educational resources
Patients, caregivers & advocates working together for a cure
Therapies in active development
Therapeutic clinical trials underway
Find the Support and Resources You Need​
Managing pancreatitis can be overwhelming, but you are not alone. We’ve gathered expert-reviewed resources to help patients and families navigate their journey. From educational toolkits to patient support groups, our resources are designed to empower you with knowledge and community.
Your support can change lives.
Mission: Cure is a nonprofit working to find effective treatments and a cure for pancreatitis, a little-known, life-altering disease that causes intense pain in both children and adults.
Families like Atlas’s are fighting for answers, better care, and hope.
We cannot do this without your support.
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality.
Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors — seeking to generate social and not just financial returns — have made curing disease a priority.
Latest News
Mission: Cure Announces Partnership With Cibus Therapeutics and Greenstone Biosciences to Advance a New Anti-Inflammatory Treatment for Chronic Pancreatitis
December 2025 — Mission: Cure is pleased to announce a collaboration with Cibus Therapeutics and Greenstone Biosciences, two biotechnology companies working together developing next-generation treatments
A Community for People Navigating High Triglycerides
High triglyceride levels can affect people in different ways. High triglycerides often don’t cause symptoms, so many people don’t realize their levels are elevated until
FDA Approves New Treatment for Familial Chylomicronemia Syndrome (FCS)
We have some exciting news for people living with pancreatitis caused by the FCS genetic mutation. The FDA has approved REDEMPLO® (plozasiran), a new treatment